AdvaMed®
  • Our Work
    • Key Issues
    • Policy Areas
    • Sectors
    • Emerging Policy & Tariff Response Center
  • Industry Updates
    • Reports and Insights
    • Research & Policy Papers
    • Medtech POV with Scott Whitaker
    • Medtech POV Blog
    • Press Releases
  • Join
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events & Education
    • All Events & Education
    • In Person
    • Online
Login

Shipments of COVID-19 Molecular Tests Exceed 150 Million: AdvaMed®’s COVID-19 Testing Supply Registry

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million, based on the latest data…

The Virtual The MedTech Conference Week 2 Continues World-Class Offerings

WASHINGTON, D.C.– Week 2 of The Virtual The MedTech Conference, powered by AdvaMed®, brings an additional slate of on-demand content as the premier meeting of the medical technology community continues its…

Digital Health / Health Access / Regulatory Affairs

The Virtual The MedTech Conference Opens with On-Demand Offerings

WASHINGTON, D.C. – The Virtual The MedTech Conference, powered by AdvaMed®, kicks off its first week of on-demand content with a slate of informative sessions providing something for everyone in…

AdvaMed® Commends CMS Proposed Rule to Improve Coverage For Innovative, “Breakthrough” Technologies

WASHINGTON, D.C. – Following today’s issuance by the Centers for Medicare and Medicaid Services (CMS) of a proposed rule on Medicare coverage of innovative technologies, the Advanced Medical Technology Association® (AdvaMed®)…

Diagnostics / VALID Act

AdvaMed® Statement on HHS Rescission of Policies on Laboratory Developed Tests During COVID and Beyond

WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement: “AdvaMed® fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle…

COVID-19 / Diagnostics / VALID Act

AdvaMed® Statement on HHS Rescission of Policies on Laboratory Developed Tests During COVID and Beyond

WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement:

House Bill Provides Economic Relief to Medtech Start-Ups Struggling Due to COVID

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from Ashley Wittorf, Executive Director, AdvaMed Accel® & Global Head, Investor Relations, on bipartisan legislation (HR 7917) introduced in the…

Diagnostics

AdvaMed®’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 Million

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…

AdvaMed®’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 Million

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…

Supply Chain

AdvaMed® Expands VentConnect Platform to Advance Production of COVID Medtech

WASHINGTON, D.C. – To ensure production of vital medical devices and diagnostic tests during this critical time and to help prevent future supply chain issues, the Advanced Medical Technology Association® (AdvaMed®) announced that…

  • Previous
  • 1
  • …
  • 35
  • 36
  • 37
  • …
  • 52
  • Next
AdvaMed®

Stay up to date with AdvaMed®.

Subscribe for Updates
  • Join
  • Member Center
  • Industry Updates
  • Contact
  • FAQs
  • Events & Education
  • Careers
  • The Story of Medtech
  • The MedTech Conference
  • Because Every Moment Matters 

Copyright 2026 AdvaMed®

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Accessibility Statement
  • 中文
  • youtube
  • linkedin
  • facebook
  • X
  • medium
  • instagram

Menu

  • Our Work
    • Key Issues
    • Policy Areas
    • Sectors
    • Emerging Policy & Tariff Response Center
  • Industry Updates
    • Reports and Insights
    • Research & Policy Papers
    • Medtech POV with Scott Whitaker
    • Medtech POV Blog
    • Press Releases
  • Join
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events & Education
    • All Events & Education
    • In Person
    • Online
  • Login
  • About AdvaMed®
    • Our Leadership
    • Initiatives
    • Jobs at AdvaMed®
    • Contact Us
  • Membership & Join
    • Membership Directory
    • Associate Membership Directory
    • Membership Application
    • Awards
  • Medical Device Industry Facts
    • Safety & Quality
    • Job Creation
  • AdvaMed Accel®
    • Accel Member Directory
    • Partnerships and Opportunities
  • AdvaMedDx®
    • AdvaMed®DX Members
    • AdvaMedDx® Resources
    • Join AdvaMed®DX
  • AdvaMed® Digital Health Tech™
    • AdvaMed® Digital Health Tech™ Members DRAFT
  • AdvaMed® Medical Imaging™
    • AdvaMed® Imaging® Members

Search